Literature DB >> 15702238

Endothelium dysfunction markers in patients with diabetic retinopathy.

Krzysztof Siemianowicz1, Tomasz Francuz, Jan Gminski, Alicja Telega, Marcin Syzdól.   

Abstract

Diabetes mellitus leads to endothelium dysfunction and an accelerated progression of atherosclerosis. Vascular complications of diabetes mellitus can affect not only large and medium arteries resulting in coronary heart disease and peripheral arteries diseases, but also small vessels leading to retinopathy and nephropathy. Intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), E-selectin and von Willebrand factor (vWF) are considered as markers of endothelium dysfunction. The aim of our study was to evaluate plasma levels of ICAM-1, VCAM-1, E-selectin and vWF in patients with type 2 diabetes mellitus receiving insulin therapy and who had diabetic non-proliferative retinopathy, proliferative retinopathy, or did not develop diabetic retinopathy. There were no statistically significant differences between studied groups in any of evaluated endothelium dysfunction markers. There was no statistically significant correlation between measured parameters and a period of diabetic history. None of the studied markers presented a significant correlation with a period of insulin treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702238

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Jacek Karpe; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2009-12-11       Impact factor: 3.984

2.  Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

3.  Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow.

Authors:  Thanh T Nguyen; Jonathan E Shaw; Carol Robinson; Ryo Kawasaki; Jie Jin Wang; Andreas J Kreis; Tien Y Wong
Journal:  Diabetes Care       Date:  2011-04-22       Impact factor: 19.112

4.  Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy.

Authors:  Thanh T Nguyen; Ryo Kawasaki; Jie Jin Wang; Andreas J Kreis; Jonathan Shaw; Walthard Vilser; Tien Y Wong
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 17.152

Review 5.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.